Alcidion Launches Miya Results Tracking in Response to Patient Safety Challenge
A systemic cause of patient harm could be better avoided with the help of technology, following the launch of Miya Results Tracking by health tech company Alcidion.
The new digital solution is designed to reduce the risk of test results not being followed up. It has been built to help healthcare professionals in hospital settings to more easily visualise, prioritise and acknowledge high volumes of tests results generated for patients every day, and to take appropriate action in a timely manner.
Bayer moves ahead with advancements across its comprehensive Radiology portfolio as well as expanded offering in its digital business and services. The company announced that new clinical and pre-clinical data for gadoquatrane, Bayer's novel investigational macrocyclic gadolinium-based contrast agent currently in Phase III clinical development, will be presented at the 2024 European Congress of Radiology (ECR) - taking place from February 28 to March 3, 2024, in Vienna, Austria. 
The trust's Oldham laboratory has completed technical go-live, with its Salford site also set to follow. Collectively the laboratories provide a wide range of general and specialist pathology services that support diagnoses for patients in the region. This includes one of the largest dermatology departments in the country, and gynaecology services that cover six hospitals. 
Highland Marketing has been looking ahead to 2024 and asking health tech leaders what they expect to see in health tech this year. The chair of the advisory board, Jeremy Nettle, argues that with a general election approaching, the NHS needs a period of stability to address the pressures it is facing.